Cargando…

Enteropathogenic Escherichia coli EspH-Mediated Rho GTPase Inhibition Results in Desmosomal Perturbations

BACKGROUND & AIMS: The diarrheagenic pathogen, enteropathogenic Escherichia coli (EPEC), uses a type III secretion system to deliver effector molecules into intestinal epithelial cells (IECs). While exploring the basis for the lateral membrane separation of EPEC-infected IECs, we observed infect...

Descripción completa

Detalles Bibliográficos
Autores principales: Roxas, Jennifer Lising, Monasky, Ross Calvin, Roxas, Bryan Angelo P., Agellon, Al B., Mansoor, Asad, Kaper, James B., Vedantam, Gayatri, Viswanathan, V.K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039986/
https://www.ncbi.nlm.nih.gov/pubmed/30003123
http://dx.doi.org/10.1016/j.jcmgh.2018.04.007
_version_ 1783338776526848000
author Roxas, Jennifer Lising
Monasky, Ross Calvin
Roxas, Bryan Angelo P.
Agellon, Al B.
Mansoor, Asad
Kaper, James B.
Vedantam, Gayatri
Viswanathan, V.K.
author_facet Roxas, Jennifer Lising
Monasky, Ross Calvin
Roxas, Bryan Angelo P.
Agellon, Al B.
Mansoor, Asad
Kaper, James B.
Vedantam, Gayatri
Viswanathan, V.K.
author_sort Roxas, Jennifer Lising
collection PubMed
description BACKGROUND & AIMS: The diarrheagenic pathogen, enteropathogenic Escherichia coli (EPEC), uses a type III secretion system to deliver effector molecules into intestinal epithelial cells (IECs). While exploring the basis for the lateral membrane separation of EPEC-infected IECs, we observed infection-induced loss of the desmosomal cadherin desmoglein-2 (DSG2). We sought to identify the molecule(s) involved in, and delineate the mechanisms and consequences of, EPEC-induced DSG2 loss. METHODS: DSG2 abundance and localization was monitored via immunoblotting and immunofluorescence, respectively. Junctional perturbations were visualized by electron microscopy, and cell–cell adhesion was assessed using dispase assays. EspH alanine-scan mutants as well as pharmacologic agents were used to evaluate impacts on desmosomal alterations. EPEC-mediated DSG2 loss, and its impact on bacterial colonization in vivo, was assessed using a murine model. RESULTS: The secreted virulence protein EspH mediates EPEC-induced DSG2 degradation, and contributes to desmosomal perturbation, loss of cell junction integrity, and barrier disruption in infected IECs. EspH sequesters Rho guanine nucleotide exchange factors and inhibits Rho guanosine triphosphatase signaling; EspH mutants impaired for Rho guanine nucleotide exchange factor interaction failed to inhibit RhoA or deplete DSG2. Cytotoxic necrotizing factor 1, which locks Rho guanosine triphosphatase in the active state, jasplakinolide, a molecule that promotes actin polymerization, and the lysosomal inhibitor bafilomycin A, respectively, rescued infected cells from EPEC-induced DSG2 loss. Wild-type EPEC, but not an espH-deficient strain, colonizes mouse intestines robustly, widens paracellular junctions, and induces DSG2 re-localization in vivo. CONCLUSIONS: Our studies define the mechanism and consequences of EPEC-induced desmosomal alterations in IECs. These perturbations contribute to the colonization and virulence of EPEC, and likely related pathogens.
format Online
Article
Text
id pubmed-6039986
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-60399862018-07-12 Enteropathogenic Escherichia coli EspH-Mediated Rho GTPase Inhibition Results in Desmosomal Perturbations Roxas, Jennifer Lising Monasky, Ross Calvin Roxas, Bryan Angelo P. Agellon, Al B. Mansoor, Asad Kaper, James B. Vedantam, Gayatri Viswanathan, V.K. Cell Mol Gastroenterol Hepatol Original Research BACKGROUND & AIMS: The diarrheagenic pathogen, enteropathogenic Escherichia coli (EPEC), uses a type III secretion system to deliver effector molecules into intestinal epithelial cells (IECs). While exploring the basis for the lateral membrane separation of EPEC-infected IECs, we observed infection-induced loss of the desmosomal cadherin desmoglein-2 (DSG2). We sought to identify the molecule(s) involved in, and delineate the mechanisms and consequences of, EPEC-induced DSG2 loss. METHODS: DSG2 abundance and localization was monitored via immunoblotting and immunofluorescence, respectively. Junctional perturbations were visualized by electron microscopy, and cell–cell adhesion was assessed using dispase assays. EspH alanine-scan mutants as well as pharmacologic agents were used to evaluate impacts on desmosomal alterations. EPEC-mediated DSG2 loss, and its impact on bacterial colonization in vivo, was assessed using a murine model. RESULTS: The secreted virulence protein EspH mediates EPEC-induced DSG2 degradation, and contributes to desmosomal perturbation, loss of cell junction integrity, and barrier disruption in infected IECs. EspH sequesters Rho guanine nucleotide exchange factors and inhibits Rho guanosine triphosphatase signaling; EspH mutants impaired for Rho guanine nucleotide exchange factor interaction failed to inhibit RhoA or deplete DSG2. Cytotoxic necrotizing factor 1, which locks Rho guanosine triphosphatase in the active state, jasplakinolide, a molecule that promotes actin polymerization, and the lysosomal inhibitor bafilomycin A, respectively, rescued infected cells from EPEC-induced DSG2 loss. Wild-type EPEC, but not an espH-deficient strain, colonizes mouse intestines robustly, widens paracellular junctions, and induces DSG2 re-localization in vivo. CONCLUSIONS: Our studies define the mechanism and consequences of EPEC-induced desmosomal alterations in IECs. These perturbations contribute to the colonization and virulence of EPEC, and likely related pathogens. Elsevier 2018-04-27 /pmc/articles/PMC6039986/ /pubmed/30003123 http://dx.doi.org/10.1016/j.jcmgh.2018.04.007 Text en © 2018 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Research
Roxas, Jennifer Lising
Monasky, Ross Calvin
Roxas, Bryan Angelo P.
Agellon, Al B.
Mansoor, Asad
Kaper, James B.
Vedantam, Gayatri
Viswanathan, V.K.
Enteropathogenic Escherichia coli EspH-Mediated Rho GTPase Inhibition Results in Desmosomal Perturbations
title Enteropathogenic Escherichia coli EspH-Mediated Rho GTPase Inhibition Results in Desmosomal Perturbations
title_full Enteropathogenic Escherichia coli EspH-Mediated Rho GTPase Inhibition Results in Desmosomal Perturbations
title_fullStr Enteropathogenic Escherichia coli EspH-Mediated Rho GTPase Inhibition Results in Desmosomal Perturbations
title_full_unstemmed Enteropathogenic Escherichia coli EspH-Mediated Rho GTPase Inhibition Results in Desmosomal Perturbations
title_short Enteropathogenic Escherichia coli EspH-Mediated Rho GTPase Inhibition Results in Desmosomal Perturbations
title_sort enteropathogenic escherichia coli esph-mediated rho gtpase inhibition results in desmosomal perturbations
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039986/
https://www.ncbi.nlm.nih.gov/pubmed/30003123
http://dx.doi.org/10.1016/j.jcmgh.2018.04.007
work_keys_str_mv AT roxasjenniferlising enteropathogenicescherichiacoliesphmediatedrhogtpaseinhibitionresultsindesmosomalperturbations
AT monaskyrosscalvin enteropathogenicescherichiacoliesphmediatedrhogtpaseinhibitionresultsindesmosomalperturbations
AT roxasbryanangelop enteropathogenicescherichiacoliesphmediatedrhogtpaseinhibitionresultsindesmosomalperturbations
AT agellonalb enteropathogenicescherichiacoliesphmediatedrhogtpaseinhibitionresultsindesmosomalperturbations
AT mansoorasad enteropathogenicescherichiacoliesphmediatedrhogtpaseinhibitionresultsindesmosomalperturbations
AT kaperjamesb enteropathogenicescherichiacoliesphmediatedrhogtpaseinhibitionresultsindesmosomalperturbations
AT vedantamgayatri enteropathogenicescherichiacoliesphmediatedrhogtpaseinhibitionresultsindesmosomalperturbations
AT viswanathanvk enteropathogenicescherichiacoliesphmediatedrhogtpaseinhibitionresultsindesmosomalperturbations